rs886039347
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM5PP3PP5_Very_Strong
The NM_001399.5(EDA):c.1069C>T(p.Arg357Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,098,191 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R357P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001399.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDA | NM_001399.5 | c.1069C>T | p.Arg357Trp | missense_variant | 8/8 | ENST00000374552.9 | NP_001390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDA | ENST00000374552.9 | c.1069C>T | p.Arg357Trp | missense_variant | 8/8 | 1 | NM_001399.5 | ENSP00000363680 | P4 | |
EDA | ENST00000374553.6 | c.1063C>T | p.Arg355Trp | missense_variant | 8/8 | 1 | ENSP00000363681 | A1 | ||
EDA | ENST00000524573.5 | c.1054C>T | p.Arg352Trp | missense_variant | 8/8 | 1 | ENSP00000432585 | A1 | ||
EDA | ENST00000616899.1 | c.673C>T | p.Arg225Trp | missense_variant | 7/7 | 5 | ENSP00000481963 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1098191Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363545
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 23, 2022 | Not observed in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23991204, 28045201) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | EDA: PM1, PM2, PM5, PS4:Moderate - |
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Apr 22, 2021 | - - |
Hypohidrotic X-linked ectodermal dysplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 357 of the EDA protein (p.Arg357Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of X-linked hypohidrotic ectodermal dysplasia (PMID: 28045201, 31796081; Invitae). ClinVar contains an entry for this variant (Variation ID: 265112). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EDA protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
See cases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Jul 17, 2019 | ACMG categories: PM1,PM2,PP1,PP3 - |
EDA-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 30, 2024 | The EDA c.1069C>T variant is predicted to result in the amino acid substitution p.Arg357Trp. This variant has been reported in the hemizygous state in individuals with hypohidrotic ectodermal dysplasia (Arte et al. 2013. PubMed ID: 23991204; Monroy-Jaramillo et al. 2017. PubMed ID: 28045201; Martínez-Romero et al 2019. PubMed ID: 31796081). This variant has not been reported in a large population database, indicating this variant is rare and has been interpreted as pathogenic and likely pathogenic by other laboratories in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/265112/). Additionally, a different missense change impacting the same amino acid (c.1070G>C, p.Arg357Pro) has been reported in individuals with hypohidrotic ectodermal dysplasia (Monreal et al. 1998. PubMed ID: 9683615; Goodwin et al. 2014. PubMed ID: 25333067), indicating the p.Arg357 residue may be important for EDA function. Taken together, the c.1069C>T (p.Arg357Trp) variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at